Puma Biotechnology Inc - Company Profile
Powered by 
All the sales intelligence you need on Puma Biotechnology Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Puma Biotechnology Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Puma Biotechnology Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Puma Biotechnology Inc (Puma Biotechnology) is a biopharmaceutical company that focuses on the development and commercialization of cancer care products. A Neratinib-based pipeline, focusing on research and development activities, and marketed product: Nerlynx are its strengths, even as dependence on limited number of customers could be a major cause for concern. The company could benefit from the growing market for cancer treatment, growth initiatives, and promising clinical trials. However, huge competition, stringent regulations, and dependence on third-party manufacturers could affect the company's growth prospects.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer